A Randomized, Double-blind, Placebo-controlled, Phase III Study of Oxaliplatin/5-fluorouracil/Leucovorin With PTK787/ZK 222584 or Placebo in Patients With Previously Treated Metastatic Adenocarcinoma of the Colon or Rectum.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 08 Mar 2017

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vatalanib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
Indications Colorectal cancer
Focus Registrational; Therapeutic Use
Acronyms CONFIRM-2
Sponsors Novartis

Most Recent Events

04 Apr 2011 Results published in the Journal of Clinical Oncology.
04 Apr 2011 Primary endpoint 'Overall-survival' has not been met, based on results published in the Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology.
03 Feb 2010 Official Title amended as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight